This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jeffrey M. Rimmer, MD; James F. Horn, MD; F. John Gennari, MD

Arch Intern Med. 1987;147(5):867-869.

Abstract
• A wide array of drugs in common use can produce hyperkalemia. We reviewed our experience with severe hyperkalemia (potassium levels >5.9 mEq/L [>5.9 mmol/L]) in adult inpatients during a one-year period, to evaluate the extent to which drugs could be implicated in this electrolyte disorder. Excluding hemolyzed samples, single unexplained values, and measurements obtained during cardiopulmonary bypass or resuscitation, drug therapy was a probable contributing factor in more than 60% of the hyperkalemic episodes; in 25%, drugs were temporally linked to the onset of the hyperkalemia. In declining order of frequency, the drugs associated with hyperkalemia were potassium chloride, captopril, nonsteroidal anti-inflammatory agents, and potassium-sparing diuretics. In more than 80% of the drug-related hyperkalemic episodes, potassium regulation was compromised by underlying disease states. The most common was renal insufficiency, followed by diabetes mellitus and metabolic acidosis. This review underscores the dictum that caution should be exercised when drugs with hyperkalemic potential are used in patients with impaired potassium homeostasis.

(Arch Intern Med 1987;147:867-869)

Author Affiliations
From the University of Vermont College of Medicine, Burlington. Dr Horn is now with Albany (NY) Medical College.

Footnotes
Accepted for publication Oct 22,1986.

Reprint requests to D305 Given Bldg, University of Vermont College of Medicine, Burlington, VT 05405 (Dr Gennari).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Low ratios of sodium to potassium in the serum of 238 dogs
Nielsen et al.
Vet Rec. 2008;162:431-435.
ABSTRACT | FULL TEXT  

Factors Associated with Time to Follow-up of Severe Hyperkalemia in the Ambulatory Setting
Moore et al.
American Journal of Medical Quality 2007;22:428-437.
ABSTRACT  

Effect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal function.
Schurmann et al.
J Clin Pharmacol 2006;46:867-875.
ABSTRACT | FULL TEXT  

Follow-up of Markedly Elevated Serum Potassium Results in the Ambulatory Setting: Implications for Patient Safety
Moore et al.
American Journal of Medical Quality 2006;21:115-124.
ABSTRACT  

Hyperkalemia: A Review
Evans and Greenberg
J Intensive Care Med 2005;20:272-290.
ABSTRACT  

Managing Hyperkalemia Caused by Inhibitors of the Renin-Angiotensin-Aldosterone System
Palmer
NEJM 2004;351:585-592.
FULL TEXT  

Acid-Base and Electrolyte Abnormalities Observed in Patients Receiving Cardiovascular Drugs
Miltiadous et al.
J CARDIOVASC PHARMACOL THER 2003;8:267-276.
ABSTRACT  

The Treatment of Hypertension in Adult Patients With Diabetes
Arauz-Pacheco et al.
Diabetes Care 2002;25:134-147.
FULL TEXT  

Angiotensin II Receptor Blockers: Equal or Preferred Substitutes for ACE Inhibitors?
Grossman et al.
Arch Intern Med 2000;160:1905-1911.
FULL TEXT  

Chronic Renal Insufficiency: A Diagnostic and Therapeutic Approach
Rahman and Smith
Arch Intern Med 1998;158:1743-1752.
ABSTRACT | FULL TEXT  

Hypokalemia
Gennari
NEJM 1998;339:451-458.
FULL TEXT  

Hyperkalemia in Hospitalized Patients: Causes, Adequacy of Treatment, and Results of an Attempt to Improve Physician Compliance With Published Therapy Guidelines
Acker et al.
Arch Intern Med 1998;158:917-924.
ABSTRACT | FULL TEXT  

Trimethoprim-Induced Hyperkalemia in a Patient with AIDS
Choi et al.
NEJM 1993;328:703-706.
FULL TEXT